casein kinase 1 delta inhibitor (Janssen Pharmaceuticals)

N/A

Report date: 2025/03/14 16:43:20
NME

Base Information

Drug Namecasein kinase 1 delta inhibitor (Janssen Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCasein kinase I isoform delta inhibitors
TargetsCasein kinase I isoform delta
Therapy Area/IndicationsMental DisordersSleep Disorders, Circadian Rhythm
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJanssen Pharmaceutica NV
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Pharmaceutica NV
Inactive CompaniesN/A
Active IndicationsSleep Disorders, Circadian Rhythm
Inactive IndicationsMental Disorders

Other Information

ATC CodeN/A
Related LinksN/A